NDC 59572-515

Abecma

Idecabtagene Vicleucel

Abecma is a Intravenous Suspension in the Cellular Therapy category. It is labeled and distributed by Celgene Corporation. The primary component is Idecabtagene Vicleucel.

• Product ID: 59572-515_1d76d5fe-64a7-4b3b-8675-bcf43bdb7ed7
• NDC: 59572-515
• Product Type: Cellular Therapy
• Proprietary Name: Abecma
• Generic Name: Idecabtagene Vicleucel
• Dosage Form: Suspension
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-03-26
• Marketing Category: BLA /
• Application Number: BLA125736
• Labeler Name: Celgene Corporation
• Substance Name: IDECABTAGENE VICLEUCEL
• Active Ingredient Strength: 300000000 1/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 59572-515-01

1 SUSPENSION in 1 BAG (59572-515-01)

• Marketing Start Date: 2021-03-26
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details